Rolfe Mark 4
4 · FACET BIOTECH CORP · Filed Apr 21, 2010
Insider Transaction Report
Form 4
Rolfe Mark
Sr. Vice Pres. and CSO
Transactions
- Disposition from Tender
Common Stock
2010-04-20$27.00/sh−1,113$30,051→ 21,333 total
Footnotes (1)
- [F1]Includes shares not previously reported that were acquired under a Section 423 employee stock purchase plan.